title: International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies.
authors.affiliation: Department of Dermatology, University of Michigan Medical Center, Ann Arbor, MI, U.S.A. cellis@med.umich.edu
authors.forename: C
authors.initials: C
authors.lastname: Ellis
authors.forename: T
authors.initials: T
authors.lastname: Luger
authors.forename: D
authors.initials: D
authors.lastname: Abeck
authors.forename: R
authors.initials: R
authors.lastname: Allen
authors.forename: R A C
authors.initials: RA
authors.lastname: Graham-Brown
authors.forename: Y
authors.initials: Y
authors.lastname: De Prost
authors.forename: L F
authors.initials: LF
authors.lastname: Eichenfield
authors.forename: C
authors.initials: C
authors.lastname: Ferrandiz
authors.forename: A
authors.initials: A
authors.lastname: Giannetti
authors.forename: J
authors.initials: J
authors.lastname: Hanifin
authors.forename: J Y M
authors.initials: JY
authors.lastname: Koo
authors.forename: D
authors.initials: D
authors.lastname: Leung
authors.forename: C
authors.initials: C
authors.lastname: Lynde
authors.forename: J
authors.initials: J
authors.lastname: Ring
authors.forename: R
authors.initials: R
authors.lastname: Ruiz-Maldonado
authors.forename: J-H
authors.initials: JH
authors.lastname: Saurat
mesh_terms: D000287:Administration, Topical; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003876:Dermatitis, Atopic / Q000209:etiology / Q000628:therapy*; D003879:Dermatologic Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D016559:Tacrolimus / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; C117268:pimecrolimus; D016559:Tacrolimus